Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This Phase 3 study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The study is planned to run for about 18 months with individual study participation lasting about two (2) weeks.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Diagnoza raka jajnika (nowy lub nawrotowy) lub silne podejrzenie raka jajnika, otrzewnej lub jajowodu
- •Badanie obrazowe (MRI, PET lub CT) wykonane do 30 dni przed włączeniem do badania potwierdzające guz lub nawrót
- •Kobieta w wieku co najmniej 18 lat
- •Prawidłowe funkcje organów wewnętrznych i szpiku kostnego, zdolna do operacji
- •Prawidłowe wyniki badań laboratoryjnych (wątroba, nerki)
- •Umiejętność zrozumienia i podpisania dokumentu zgody na udział w badaniu
- •Dla kobiet mogących zajść w ciążę: zobowiązanie do stosowania skutecznej antykoncepcji przez 42 dni po podaniu leku
✗ Disqualifies
- •Planowana endoskopia ginekologiczna (laparoskopia) bez możliwości otwarcia brzucha i usunięcia nowotworu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (11)
Mayo Clinic Arizona
Phoenix, United States
Mayo Clinic Florida
Jacksonville, United States
Luminis Health Anne Arundel Medical Center
Annapolis, United States
University of Maryland
Baltimore, United States
Mayo Clinic Methodist Campus
Rochester, United States
Mount Sinai
New York, United States
The Cleveland Clinic Foundation
Cleveland, United States
WellSpan Health
York, United States
Riverside Health
Newport News, United States
CAMC Institute for Academic Medicine - Cancer Research Center
Charleston, United States
WVU Cancer Institute
Morgantown, United States
Trial contact
Michael Giammona
Ron Mims
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.